Part I: Pathogenetic role of peroxynitrite in the development of diabetes and diabetic vascular complications: Studies with FP15, a novel potent peroxynitrite decomposition catalyst

Molecular Medicine

Volumn 8, Issue 10, 2002, Pages 571-580

  Szabó, Csaba ^a,b   Mabley, Jon G ^a   Moeller, Suzanne M ^c   Shimanovich, Roman ^c   Pacher, Pál ^a   Virág, László ^a   Soriano, Francisco G ^b   Van Duzer, John H ^a   Williams, William ^a   Salzman, Andrew L ^a   Groves, John T ^c  

^a INOTEK CORPORATION   (United States)

^b RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^c PRINCETON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FP 15; PEROXYNITRITE; PEROXYNITRITE DECOMPOSITION CATALYST; PORPHYRIN DERIVATIVE; TETRAKIS 2 (TRIETHYLENE GLYCOL METHYL ETHER)PYRIDYLPORPHYRIN; TYROSINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; CARDIOVASCULAR DISEASE; CATALYST; CELL DEATH; CONTROLLED STUDY; CYTOTOXICITY; DIABETES MELLITUS; HYPERGLYCEMIA; MALE; MOUSE; NONHUMAN; PANCREAS ISLET BETA CELL; PATHOGENESIS; PRIORITY JOURNAL; STREPTOZOCIN DIABETES; SYNTHESIS;

EID: 0036821898     PISSN: 10761551     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf03402167     Document Type: Article

References (51)

1. Beckman JS, Beckman TW, Chen J, Marshall PA, Freeman BA. (1990) Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc. Natl. Acad. Sci. U. S. A. 87: 1620-1624.
2. Ischiropoulos H, Zhu L, Chen J, et al. (1992) Peroxynitrite-mediated tyrosine nitration catalyzed by superoxide dismutase. Arch. Biochem. Biophys. 298: 431-437.
3. Estevez AG, Radi R, Barbeito L, Shin JT, Thompson JA, Beckman JS. (1995) Peroxynitrite-induced cytotoxicity in PC12 cells: evidence for an apoptotic mechanism differentially modulated by neurotrophic factors. J. Neurochem. 65: 1543-1550.
4. Szabó C, Zingarelli B, O'Connor M, Salzman AL. (1996) DNA strand breakage, activation of poly (ADP-ribose) synthetase, and cellular energy depletion are involved in the cytotoxicity of macrophages and smooth muscle cells exposed to peroxynitrite. Proc. Natl. Acad. Sci. U. S. A. 93: 1753-1758.
5. Virág L, Scott GS, Marmer D, Cuzzocrea S, Salzman AL, Szabó C. (1998) Peroxynitrite-induced thymocyte apoptosis: the role of caspases and poly (ADP-ribose) synthetase (PARS) activation. Immunology 94: 345-355.
6. Estevez AG, Spear N, Manuel SM, et al. (1998) Nitric oxide and superoxide contribute to motor neuron apoptosis induced by trophic factor deprivation. J. Neurosci. 18: 923-939.
7. Beckman JS, Koppenol WH. (1996) Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. Am. J. Physiol. 271: C1424-C1437.
8. Szabó C. (1996) The pathophysiological role of peroxynitrite in shock, inflammation, and ischemia-reperfusion injury. Shock 6: 79-88.
9. Greenacre SA, Ischiropoulos H. (2001) Tyrosine nitration: localisation, quantification, consequences for protein function and signal transduction. Free Radic. Res. 34: 541-581.
10. Suarez-Pinzon WL, Szabó C, Rabinovitch A. (1997) Development of autoimmune diabetes in NOD mice is associated with the formation of peroxynitrite in pancreatic islet beta-cells. Diabetes 46: 907-911.
11. Kastenbauer S, Koedel U, Becker BF, Pfister HW. (2002) Oxidative stress in bacterial meningitis in humans. Neurology 58: 186-191.
12. Soriano FG, Virág L, Jagtap P, et al. (2001) Diabetic endothelial dysfunction: the role of poly(ADP-ribose) polymerase activation. Nature Med. 7: 108-113.
13. Thuraisingham RC, Nott CA, Dodd SM, Yaqoob MM. (2000) Increased nitrotyrosine staining in kidneys from patients with diabetic nephropathy. Kidney Int. 57: 968-972.
14. Szabó C, Cuzzocrea S, Zingarelli B, O'Connor M, Salzman AL. (1997) Endothelial dysfunction in a rat model of endotoxic shock. Importance of the activation of poly (ADP-ribose) synthetase by peroxynitrite. J. Clin. Invest. 100: 723-735.
15. Villa LM, Salas E, Darley-Usmar VM, Radomski MW, Moncada S. (1994) Peroxynitrite induces both vasodilatation and impaired vascular relaxation in the isolated perfused rat heart. Proc. Natl. Acad. Sci. U. S. A. 91: 2383-2387.
16. Ferdinandy P, Panas D, Schulz R. (1999) Peroxynitrite contributes to spontaneous loss of cardiac efficiency in isolated working rat hearts. Am. J. Physiol. 276: H1861-H1867.
17. Digerness SB, Harris KD, Kirklin JW, et al. (1999) Peroxynitrite irreversibly decreases diastolic and systolic function in cardiac muscle. Free Radic. Biol. Med. 27: 1386-1392.
18. Pasternack RF, Gillies BS, Stromsted JP. (1978) Substitution reactions of a water-soluble metalloporphyrin with azide and 1,1,3,3-tetramethyl-2-thiourea. Bioinorg Chem. 8: 33-44.
19. Shimanovich R, Groves JT. (2001) Mechanisms of peroxynitrite decomposition catalyzed by FeTMPS, a bioactive sulfonated iron porphyrin. Arch. Biochem. Biophys. 387: 307-317.
20. Mabley JG, Cunningham JM, John N, Di Matteo MA, Green IC. (1997) Transforming growth factor beta 1 prevents cytokine-mediated inhibitory effects and induction of nitric oxide synthase in the RINm5F insulin-containing beta-cell line. J. Endocrinol. 155: 567-575.
21. Mabley JG, Suarez-Pinzon WL, Hasko G, et al. (2001) Inhibition of poly (ADP-ribose) synthetase by gene disruption or inhibition with 5-iodo-6-amino-1,2-benzopyrone protects mice from multiple-low-dose-streptozotocin-induced diabetes. Br. J. Pharmacol. 133: 909-919.
22. Liaudet L, Szabo E, Timashpolsky L, Virag L, Cziraki A, Szabo C. (2001) Suppression of poly (ADP-ribose) polymerase activation by 3-aminobenzamide in a rat model of myocardial infarction: long-term morphological and functional consequences. Br. J. Pharmacol. 133: 1424-1430.
23. Lee J, Hunt JA, Groves JT. (1998) Manganese porphyrins as redox-coupled peroxynitrite reductases. J. Am. Chem. Soc. 120: 6053-6061.
24. Radi R, Beckman JS, Bush KM, Freeman BA. (1991) Peroxynitrite-induced membrane lipid peroxidation: the cytotoxic potential of superoxide and nitric oxide. Arch. Biochem. Biophys. 288: 481-487.
25. Klebanoff SJ. (1993) Reactive nitrogen intermediates and antimicrobial activity: role of nitrite. Free Radic. Biol. Med. 14: 351-360.
26. Estevez AG, Crow JP, Sampson JB, et al. (1999) Induction of nitric oxide-dependent apoptosis in motor neurons by zinc-deficient superoxide dismutase. Science 286: 2498-2500.
27. Bohle DS. (1998) Pathophysiological chemistry of nitric oxide and its oxygenation by-products. Curr. Opin. Chem. Biol. 2: 194-200.
28. Groves JT. (1999) Peroxynitrite: reactive, invasive and enigmatic. Curr. Opin. Chem. Biol. 3: 226-235.
29. Greenacre SA, Ischiropoulos H. (2001) Tyrosine nitration: localisation, quantification, consequences for protein function and signal transduction. Free Radic. Res. 34: 541-581.
30. Shi X, Rojanasakul Y, Gannett P, et al. (1994) Generation of thiyl and ascorbyl radicals in the reaction of peroxynitrite with thiols and ascorbate at physiological pH. J. Inorg. Biochem. 56: 77-86.
31. Balavoine GG, Geletti YV, Bejan D. (1997) Catalysis of peroxynitrite reactions by manganese and iron porphyrins. Nitric Oxide 1: 507-521.
32. Lee J, Hunt JA, Groves JT. (1997) Rapid decomposition of peroxynitrite by manganese porphyrin-antioxidant redox-couples. Bioorg. Med. Chem. Lett. 7: 2913-2918.
33. Groves JT, Lee J, Marla S. (1997) Detection and characterization of an oxo-manganese(V) porphyrin complex by rapid-mixing stopped-flow spectrophotometry. J. Am. Chem. Soc. 119: 6269-6273.
34. Salvemini D, Wang ZQ, Stern MK, Currie MG, Misko TP. (1998) Peroxynitrite decomposition catalysts: therapeutics for peroxynitrite-mediated pathology. Proc. Natl. Acad. Sci. U. S. A. 95: 2659-2663.
35. Lymar SV, Hurst JK. (1996) Carbon dioxide: physiological catalyst for peroxynitrite-mediated cellular damage or cellular protectant? Chem. Res. Toxicol. 9: 845-850.
36. Delaney CA, Tyrberg B, Bouwens L, Vaghef H, Hellman B, Eizirik DL. (1996) Sensitivity of human pancreatic islets to peroxynitrite-induced cell dysfunction and death. FEBS Lett. 394: 300-306.
37. Suarez-Pinzon WL, Mabley JG, Strynadka K, Power RF, Szabo C, Rabinovitch A. (2001) An inhibitor of inducible nitric oxide synthase and scavenger of peroxynitrite prevents diabetes development in NOD mice. J. Autoimmun. 16: 449-455.
38. Flodstrom M, Tyrberg B, Eizirik DL, Sandler S. (1999) Reduced sensitivity of inducible nitric oxide synthase-deficient mice to multiple low-dose streptozotocin-induced diabetes. Diabetes 48: 706-713.
39. Zouki C, Zhang SL, Chan JS, Filep JG. (2001) Peroxynitrite induces integrin-dependent adhesion of human neutrophils to endothelial cells via activation of the Raf-1/MEK/Erk pathway. FASEB J. 15: 25-27.
40. Cuzzocrea S, Misko TP, Costantino G, et al. (2000) Beneficial effects of peroxynitrite decomposition catalyst in a rat model of splanchnic artery occlusion and reperfusion. FASEB J. 14: 1061-1072.
41. Soriano FG, Mabley JG, Pacher P, Liaudet L, Szabó C. (2001) Rapid reversal of the diabetic endothelial dysfunction by pharmacological inhibition of poly(ADP-ribose) polymerase. Circ. Res. 89: 684-691.
42. Sowers JR, Epstein M, Frohlich ED. (2001) Diabetes, hypertension, and cardiovascular disease: an update. Hypertension 37: 1053-1059.
43. Frustaci A, Kajstura J, Chimenti C, et al. (2000) Myocardial cell death in human diabetes. Circ. Res. 87: 1123-1132.
44. Kajstura J, Fiordaliso F, Andreoli AM, et al. (2001) IGF-1 overexpression inhibits the development of diabetic cardiomyopathy and angiotensin II-mediated oxidative stress. Diabetes 50: 1414-1424.
45. Mihm MJ, Coyle CM, Schanbacher BL, Weinstein DM, Bauer JA. (2001) Peroxynitrite induced nitration and inactivation of myofibrillar creatine kinase in experimental heart failure. Cardiovasc. Res. 49: 798-807.
46. Turko IV, Marcondes S, Murad F. (2001) Diabetes-associated nitration of tyrosine and inactivation of succinyl-CoA:3-oxoacid CoA-transferase. Am. J. Physiol. 281: H2289-H2294.
47. Zhang X, Chen J, Graham SH, et al. (2002) Intranuclear localization of apoptosis-inducing factor and large scale DNA fragmentation after traumatic brain injury in rats and in neuronal cultures exposed to peroxynitrite. J. Neurochem. 82: 181-191.
48. Bianchi C, Wakiyama H, Faro R, et al. (2002) A novel peroxynitrite decomposition catalyst (FP-15) reduces heart infarct size in a model of acute ischemia-reperfusion. Ann. Thorac. Surg. (in press).
49. Pacher P, Liaudet L, Bai P, Virág L, Mabley JG, Szabó C. (2002) A potent peroxynitrite decomposition catalyst, FP15, protects against the development of doxorubicin-induced heart failure. FASEB J. 16: A177 (abstract).
50. Naidu BV, Krishnadasan B, Fraga C, et al. (2002) The critical role of reactive nitrogen species in lung ischemia reperfusion injury. J. Heart Lung Transplant. 21: 135 (abstr).
51. Mabley JG, Liaudet L, Pacher P, Southan GJ, Salzman AL, Szabó C. (2002) Beneficial effects of the peroxynitrite decomposition catalyst FP15 in murine models of arthritis and colitis. Mol. Med. 8: 581-590.